Agilent Technologies Inc(NYSE:A) Declares Dividend of $0.1320.

Agilent Technologies Inc (NYSE:A) had declared a cash dividend of $0.1320 on Nov 17, 2016. The shares will quote ex-dividend on Dec 29, 2016 and the record date has been fixed for Jan 3, 2017. On Nov 17, 2016 share price, the yield comes out to be 1.1493%. The dividend payable date has been fixed on Jan 25, 2017.

Agilent Technologies Inc (A) shares turned negative on Mondays trading session with the shares closing down -0.9 points or -1.96% at a volume of 31,48,538. The pessimistic mood was evident in the company shares which never went considerably beyond the level of $46.2. The peak price level was also seen at $46.2 while the days lowest was $45.01. Finally the shares closed at $45.04. The 52-week high of the shares is $48.63 while the 52-week low is $34.15. According to the latest information available, the market cap of the company is $14,593 M.

Agilent Technologies Inc(A) last announced its earnings results on Nov 15, 2016 for Fiscal Year 2016 and Q4.Company reported revenue of $1.11B. Analysts had an estimated revenue of $1.07B. Earnings per share were $0.59. The reported EPS was above estimates by $0.07 or 13.46%. Analysts had estimated an EPS of $0.52.

Several Insider Transactions has been reported to the SEC. On Oct 3, 2016, Patrick Kaltenbach (Sr Vice President) sold 2,000 shares at $47.30 per share price.Also, On Sep 7, 2016, Heidi Fields (director) sold 8,072 shares at $46.99 per share price.On Aug 30, 2016, Rodney Gonsalves (V.P., Corporate Controller) sold 8,141 shares at $47.82 per share price, according to the Form-4 filing with the securities and exchange commission.

Agilent Technologies Inc. is engaged in the life sciences diagnostics and applied chemical markets. The Company provides application focused solutions that include instruments software services and consumables for the entire laboratory workflow. The Company has three business segments: the life sciences and applied markets business the diagnostics and genomics business and the Agilent CrossLab business. The Company’s life sciences and applied markets business segment brings together the Company’s analytical laboratory instrumentation and informatics. The Company’s diagnostics and genomics business segment consists of three businesses: the Dako business the genomics business and the nucleic acid solutions business. The Company’s Agilent CrossLab business segment combines its analytical laboratory services and consumables business.

Comments (0)

Leave a Reply

Your email address will not be published. Required fields are marked *

Agilent Technologies Inc - Is it time to Sell?

Top Brokerage Firms are advising their investors on Agilent Technologies Inc. Subscribe to MoneyFlowIndex.Org Pre-Market Alerts, You will be the first to know the street buzz.